National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 67320 [2018-28337]
Download as PDF
<![CDATA[
67320
Federal Register / Vol. 83, No. 248 / Friday, December 28, 2018 / Notices
Agenda: Evaluate sleep and circadian
research activities; discussion of NIH Sleep
Disorders Research Plan Revision.
Place: National Institutes of Health, Two
Rockledge Center, Conference Room 9100–
9104, 6701 Rockledge Drive, Bethesda, MD
20892.
Time: January 18, 2019, 8:30 a.m. to 3:00
p.m.
Agenda: Coordination of inter-agency sleep
research activities; discussion of NIH Sleep
Disorders Research Plan Revision.
Place: National Institutes of Health, Two
Rockledge Center, Conference Room 9100–
9104, 6701 Rockledge Drive, Bethesda, MD
20892.
Contact Person: Michael J. Twery, Ph.D.,
Director, National Center on Sleep Disorders
Research, Division of Lung Diseases, National
Heart, Lung, and Blood Institute, National
Institutes of Health, 6701 Rockledge Drive,
Suite 10042, Bethesda, MD 20892, 301–435–
0199, twerym@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: December 21, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–28328 Filed 12–27–18; 8:45 am]
BILLING CODE 4140–01–P
Place: National Institutes of Health 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Lee G Klinkenberg, Ph.D.,
Scientific Review Program, DEA/NIAID/NIH/
DHHS, 5601 Fishers Lane, MSC–9823
Bethesda, MD 20892–9834, 301–761–7749,
lee.klinkenberg@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: January 30–31, 2019.
Time: 10:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Julio C. Aliberti, Ph.D.,
Scientific Review Officer, Immunology
Review Branch, DEA/SRP RM 3G53A,
National Institutes of Health, NIAID, 5601
Fishers Lane, MSC 9823, Rockville, MD
20892–9823, 301–761–7322, julio.aliberti@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 20, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–28341 Filed 12–27–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
amozie on DSK3GDR082PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PAR–18–633: NIAID
Clinical Trial Implementation Cooperative
Agreement (U01 Clinical Trial Required).
Date: January 22, 2019.
Time: 2:30 p.m. to 4:00 p.m..
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:13 Dec 27, 2018
Jkt 247001
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 National
Resource Review (2019/05).
Date: February 7–9, 2019.
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
Time: 3:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn by Marriott Redwood
City San Carlos, 800 E. San Carlos Ave, San
Carlos, CA.
Contact Person: Ruixia Zhou, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard., Suite 957, Bethesda,
MD 20892, 301–496–4773, zhour@
mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 BTRC Review
(2019/05).
Date: February 8, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Biomedical Imaging and
Bioengineering, Two Democracy Plaza, Suite
920, 6707 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 451–3397, sukharem@
mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 BTRC Review
Meeting (2019/05).
Date: February 13–15, 2019.
Time: 12:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Shelburne Hotel & Suites by Affinia,
303 Lexington Avenue, New York, NY 10016.
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 952, Bethesda, MD
20892, (301) 451–3397, dennis.hlasta@
mail.nih.gov.
Dated: December 21, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–28337 Filed 12–27–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 83, Number 248 (Friday, December 28, 2018)]
[Notices]
[Page 67320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-28337]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Institute
of Biomedical Imaging and Bioengineering Special Emphasis Panel.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; P41 National Resource Review
(2019/05).
Date: February 7-9, 2019.
Time: 3:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn by Marriott Redwood City San Carlos, 800 E.
San Carlos Ave, San Carlos, CA.
Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Boulevard., Suite 957,
Bethesda, MD 20892, 301-496-4773, zhour@mail.nih.gov.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; P41 BTRC Review (2019/05).
Date: February 8, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
Biomedical Imaging and Bioengineering, Two Democracy Plaza, Suite
920, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manana Sukhareva, Ph.D., Scientific Review
Officer, National Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health, 6707 Democracy Blvd.,
Suite 959, Bethesda, MD 20892, (301) 451-3397,
sukharem@mail.nih.gov.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; P41 BTRC Review Meeting
(2019/05).
Date: February 13-15, 2019.
Time: 12:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Shelburne Hotel & Suites by Affinia, 303 Lexington
Avenue, New York, NY 10016.
Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Blvd., Suite 952,
Bethesda, MD 20892, (301) 451-3397, dennis.hlasta@mail.nih.gov.
Dated: December 21, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-28337 Filed 12-27-18; 8:45 am]
BILLING CODE 4140-01-P
